Insider · CIK 0001517790

Bruhn Suzanne Louise

Reports to the SEC for 8 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001517790

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	32,750
2026-05-19	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.1K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,235 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.9K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2025-06-12	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75.2K sh	—	—	75,187
2025-06-05	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-05-22	Vigil Neuroscience, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-05-15	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	28,750
2025-05-15	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2025-03-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+33.9K sh	—	—	33,875
2024-06-13	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+26.8K sh	—	—	26,764
2024-06-10	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,506
2024-06-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,068
2024-05-08	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	22,250
2024-05-08	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+6,235 sh	—	—	6,235
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,235 sh	$7.62	−$47.5K	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,310
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2024-03-01	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+24.1K sh	—	—	24,073
2023-06-21	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+13.7K sh	—	—	19,623
2023-06-21	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	27,267
2023-06-07	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2023-06-07	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2023-05-17	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2023-05-17	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+4,500 sh	—	—	15,750
2023-03-01	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+6,235 sh	$7.62	+$47.5K	6,235
2022-08-11	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+504K sh	—	—	503,773
2022-08-11	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+121K sh	—	—	120,968
2022-08-11	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+89.3K sh	—	—	89,286
2022-07-27	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,310
2022-06-16	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-05-11	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	11,250
2022-05-11	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,204 sh	—	—	5,204
2021-06-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,465 sh	—	—	3,465
2021-06-29	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,286
2021-06-15	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-05-14	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-05-14	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	8,250
2021-03-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,173 sh	—	—	4,173
2020-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,254 sh	—	—	4,254
2020-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,325 sh	—	—	4,325

Recent filings

Accepted (ET)
May 214
Bruhn Suzanne Louise0001517790-26-000002
SEC(opens sec.gov)
Aug 54
Bruhn Suzanne Louise0000950170-25-102485
SEC(opens sec.gov)
Jun 164
Bruhn Suzanne Louise0000950170-25-086765
SEC(opens sec.gov)
Jun 94
Bruhn Suzanne Louise0001746473-25-000132
SEC(opens sec.gov)
May 234
Bruhn Suzanne Louise0000950170-25-077274
SEC(opens sec.gov)
May 164
Bruhn Suzanne Louise0001415889-25-013497
SEC(opens sec.gov)
Mar 44
Bruhn Suzanne Louise0000950170-25-032417
SEC(opens sec.gov)
Jun 174
Bruhn Suzanne Louise0001746473-24-000101
SEC(opens sec.gov)
Jun 124
Bruhn Suzanne Louise0000950170-24-072441
SEC(opens sec.gov)
Jun 74
Bruhn Suzanne Louise0000950170-24-070841
SEC(opens sec.gov)
May 104
Bruhn Suzanne Louise0001415889-24-012845
SEC(opens sec.gov)

Companies

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130